Brief: Bioceltix Signs Advisory Agreement For FDA Regulatory Support

Bioceltix SA

14/04/2026 06:04

April 14 (Reuters) - Bioceltix S.A. BCXP.WA:

SAID ON MONDAY THAT IT HAD SIGNED AN ADVISORY AGREEMENT FOR REGULATORY SUPPORT OF VETERINARY STEM CELL PRODUCTS IN US MARKET

PARTNER TO ASSIST IN DIALOGUE WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND CENTER FOR VETERINARY MEDICINE (CVM)

AGREEMENT SIGNED FOR PERIOD OF UP TO 3 YEARS

ESTIMATES ABOUT 6 TO 9 MONTHS TO REACH FIRST MEETING WITH FDA/CVM

POTENTIAL ADMINISTRATIVE FEE TOTALS $165,441 IF FEE WAIVER IS NOT GRANTED

 Source text: nEM7f94JBa
 Further company coverage: BCXP.WA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))